With IBM set to report third-quarter results this Wednesday, Wall Street is searching for signs of a turnaround after a dismal spring. Analysts expect a profit of $2.34 billion, a significant jump from last year’s $1.74 billion, yet the company’s ability to recover stalled mainframe deals remains the primary test.
After a month of darkened screens, Verizon and Starz have struck a fresh distribution agreement, restoring the premium network to Fios subscribers across the country. The resolution ends a tense impasse that began in early October when the companies failed to align on the economic terms of their expiring contract.
Shares of Cumberland Pharmaceuticals surged 18% to $7.92 on Tuesday, extending a sharp 99% year-to-date rally. Investors are positioning themselves for an October 26 announcement concerning ifetroban, a drug candidate currently under investigation for treating cardiomyopathy linked to Duchenne muscular dystrophy.
With global sales volume dipping 2% to 486,532 vehicles this past quarter, investors are bracing for a decline in Tesla’s bottom line when results drop Wednesday. Analysts anticipate net income will fall to $782.2 million, a sharp drop from the $1.37 billion reported during the same period last year.
With Meta Platforms set to report third-quarter earnings this Wednesday, Wall Street is pivoting its focus from speculative infrastructure spending to concrete returns. Analysts expect a substantial leap in net income to $17.22 billion, a sharp climb from the $2.71 billion reported during the same period last year.
Apple is funneling $100 million into the U.S. manufacturing sector, securing a three-year deal with Pennsylvania’s Perryman Co. to produce titanium for the upcoming iPhone Duo. This shift underscores a broader strategy to anchor the supply chain for the company’s first foldable device and high-end camera systems domestically.
Shares of Hertz Global Holdings surged 12% to $2.06 on Tuesday, marking a rare gain for a stock that has cratered 60% this year. The rally follows an $80 million equity injection into Oro Mobility, a standalone growth platform in which the rental giant maintains a majority stake.
Investors pushed Revolution Medicines shares up 6.8% to $194.46 after the oncology firm launched a global Phase 3 trial for its investigational drug, zoldonrasib. The company is now testing the G12D-selective inhibitor in combination with standard chemotherapy and pembrolizumab as a primary treatment for metastatic lung cancer.
Investors expecting a return to the ticker for CN Healthy Food Tech Group will have to wait longer, as Nasdaq abruptly reversed its decision to resume trading this week. The exchange confirmed that the suspension remains in effect until the Zhuhai-based distributor satisfies pending requests for additional corporate information.
After a two-week climb fueled by fears of a regional conflagration, crude oil futures pulled back on Tuesday. Traders shifted focus toward potential U.S.-Iran diplomacy, prompting a round of profit-taking that shaved roughly one dollar off the per-barrel price of West Texas Intermediate by midday in New York.
The 2 billion-pound acquisition of Netomnia by Nexfibre has hit a regulatory impasse, as the joint venture between Liberty Global, Telefonica, and InfraVia Capital Partners labeled the U.K. Competition and Markets Authority's assessment of the deal as fundamentally flawed and detached from commercial reality.
Vivendi reported a 13.8% jump in revenue for the third quarter of 2026, reaching EUR 77 million. This growth, supported by the strategic pivot of its gaming subsidiary Gameloft toward PC and console titles, allowed the company to accelerate debt reduction efforts and trim its bilateral financing agreements.
A projected decline of 300,000 barrels in commercial crude oil stocks headlines the latest industry survey, as traders brace for the U.S. Energy Information Administration’s upcoming report. The consensus among nine analysts points to a tightened market for the week ended October 16, though individual forecasts remain sharply divided.
A $25-per-barrel premium currently embedded in Brent crude futures reveals deep market anxiety over the potential for a protracted conflict in the Middle East. Goldman Sachs analysts point to shifting data in energy markets as a clear signal that investors are bracing for further regional instability.
A 6% jump in Deep Fission shares on Tuesday followed the company’s announcement of a definitive energy purchase agreement with the Great Plains Development Authority. The contract secures a commercial path for the firm’s pilot project in Parsons, Kansas, targeting an initial 150 MW capacity by late 2028.
Shareholders of American Electric Power are set to receive a larger quarterly check this winter. The Columbus-based utility provider confirmed a 2.1% hike to its dividend, elevating the payout from 95 cents to 97 cents per share, as the company continues its pattern of incremental capital returns to investors.
Rising fuel costs driven by the ongoing conflict between Israel and Iran will force a dramatic surge in European ticket prices by 2027. Michael O'Leary, chief executive of Ryanair, expects the industry to face its largest price increase in history, with individual fares potentially climbing by as much as 20 percent.
A 59% jump in share price greeted WISeSat.Space on Tuesday after the company successfully launched a 6U satellite aboard a SpaceX Falcon 9 rocket. The mission, departing from Cape Canaveral, marks a critical step in testing hardware resilience against emerging cyber and quantum-era threats.
Persistent regional instability in Iran is reshaping the bottom lines of major defense contractors, driving an unprecedented surge in orders for advanced weaponry. As governments scramble to replenish stockpiles and expand military capabilities, Northrop Grumman and RTX have both reported record-breaking backlogs that signal a sustained multi-year spending cycle.
Investors pushed MSCI shares up 5.7% to $595.49 on Tuesday, marking the firm's strongest single-day performance since October 2025. The rally followed a third-quarter earnings report that surpassed Wall Street expectations, driven by solid demand across its analytics and private capital business segments.
South San Francisco-based Lycia Therapeutics is positioning itself for a public market debut, setting a price range of $16 to $18 per share for its initial public offering. The clinical-stage biotechnology firm aims to raise significant capital to fund its drug development pipeline through the latter half of 2029.
Equifax shares surged nearly 12% to $177.18 on Tuesday after the credit bureau boosted its annual profit margin outlook. While persistent high mortgage rates forced the company to temper its revenue expectations, aggressive deployment of artificial intelligence and a influx of government contracts provided a critical buffer against the housing market slowdown.
Bitget is set to acquire Bangkok-based GMO-Z.com Cryptonomics, securing a crucial regulatory gateway into Thailand’s digital asset market. By purchasing the exchange from its Japanese parent firm, GMO Internet, the Seychelles-based company gains the legal standing necessary to navigate a region that has recently tightened oversight of foreign crypto platforms.
A 19% surge in Myriad Genetics shares followed the announcement that the company is offloading its prenatal health testing division to Labcorp. The $210 million cash deal marks a significant shift for both firms as Myriad seeks to sharpen its financial focus while Labcorp expands its specialized diagnostic footprint.
With global luxury demand cooling, all eyes turn to Hermes this Thursday as the Birkin maker prepares to report quarterly revenue expected to hit 4.12 billion euros. Analysts are tracking whether the French fashion house can maintain its historical resilience while the broader sector grapples with persistent geopolitical instability and softening consumer appetite.
Shares of the Reykjavik-based biotechnology firm jumped 8% to $5.41 in morning trading after federal regulators cleared a significant shift in production. The FDA's green light for the new manufacturing process, dubbed Process 2.0, marks a pivotal moment for the company's biosimilar to the blockbuster drug Humira.
Investors are bracing for Barclays’ third-quarter results this Thursday as the bank navigates a volatile trading environment and mounting speculation over potential tax hikes. With shares down 15% year-to-date, the market remains hyper-sensitive to any signal regarding the U.K. government's upcoming budget and its impact on banking levies.
With Nokia set to report third-quarter results this Thursday, investors are pivoting from headline profit figures to the company's ability to satisfy surging AI and cloud demand. Analysts remain focused on whether component shortages, particularly at the San Jose semiconductor plant, will constrain the company's ambitious delivery targets.
Guillermo Beade, a veteran executive previously leading North American operations for SC Johnson, will take the helm as chief operating officer at Newell Brands. His appointment marks a significant shift in the Atlanta-based company’s leadership structure as it seeks to streamline its global marketing, sales, and supply-chain divisions.
With a market capitalization hovering near $78 billion, Hilton Worldwide Holdings is abandoning the New York Stock Exchange in favor of the Nasdaq. The McLean-based hotel giant plans to migrate its ticker, HLT, to the new exchange on November 5, marking a significant departure from its long-standing home on the NYSE.
